X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (6) 6
index medicus (6) 6
aged (5) 5
capecitabine (5) 5
female (5) 5
hematology, oncology and palliative medicine (5) 5
male (5) 5
middle aged (5) 5
oncology (5) 5
radiology (5) 5
radiology, nuclear medicine & medical imaging (5) 5
radiotherapy (5) 5
cancer (4) 4
cetuximab (4) 4
chemoradiotherapy (4) 4
chemotherapy (4) 4
deoxycytidine - administration & dosage (4) 4
deoxycytidine - analogs & derivatives (4) 4
fluorouracil - administration & dosage (4) 4
fluorouracil - analogs & derivatives (4) 4
patients (4) 4
radiology and nuclear medicine (4) 4
adult (3) 3
aged, 80 and over (3) 3
antibodies, monoclonal, humanized (3) 3
antineoplastic combined chemotherapy protocols - therapeutic use (3) 3
care and treatment (3) 3
clinical trials (3) 3
combined therapy (3) 3
drug administration schedule (3) 3
neoadjuvant therapy (3) 3
neoplasms (3) 3
phase-ii (3) 3
radiation doses (3) 3
toxicity (3) 3
adenocarcinoma (2) 2
adjuvant therapy (2) 2
antibodies, monoclonal - administration & dosage (2) 2
antineoplastic agents - therapeutic use (2) 2
biopsy (2) 2
camptothecin - administration & dosage (2) 2
camptothecin - analogs & derivatives (2) 2
chemoradiation (2) 2
combination (2) 2
combined modality therapy (2) 2
diarrhea (2) 2
disease-free survival (2) 2
epidermal growth factor (2) 2
fluorouracil (2) 2
gastric cancer (2) 2
genes (2) 2
inhibition (2) 2
irinotecan (2) 2
metastatic colorectal-cancer (2) 2
mutation (2) 2
nausea (2) 2
organoplatinum compounds - administration & dosage (2) 2
oxaliplatin (2) 2
pathological complete response (2) 2
polymerase chain reaction (2) 2
proto-oncogene proteins b-raf - genetics (2) 2
radiation-therapy (2) 2
radiotherapy dosage (2) 2
rectal cancer (2) 2
rectal neoplasms - drug therapy (2) 2
rectal neoplasms - genetics (2) 2
rectal neoplasms - pathology (2) 2
rectal neoplasms - radiotherapy (2) 2
rectum (2) 2
research (2) 2
stomach cancer (2) 2
stomach neoplasms - drug therapy (2) 2
stomach neoplasms - radiotherapy (2) 2
trial (2) 2
1st-line treatment (1) 1
205923-56-4 (1) 1
3d-crt (1) 1
5-fluorouracil (1) 1
918504-65-1 (1) 1
abridged index medicus (1) 1
acne-like skin rash (1) 1
adenocarcinoma - drug therapy (1) 1
adenocarcinoma - genetics (1) 1
adenocarcinoma - pathology (1) 1
adenocarcinoma - radiotherapy (1) 1
aminotransferases (1) 1
antibiotics (1) 1
antibodies (1) 1
antibodies, monoclonal - adverse effects (1) 1
antibodies, monoclonal - therapeutic use (1) 1
antineoplastic agents - adverse effects (1) 1
antineoplastic combined chemotherapy protocols - administration & dosage (1) 1
antineoplastic combined chemotherapy protocols - adverse effects (1) 1
article (1) 1
astrocytes (1) 1
b raf kinase (1) 1
biomarkers - blood (1) 1
biomarkers, tumor - metabolism (1) 1
body (1) 1
braf (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2009, Volume 74, Issue 5, pp. 1487 - 1493
Purpose To evaluate the safety and efficacy of preoperative radiotherapy (RT) in combination with cetuximab, capecitabine, and irinotecan in patients with... 
Radiology | Hematology, Oncology and Palliative Medicine | Irinotecan | Rectal cancer | Cetuximab | Capecitabine | Chemoradiotherapy | I/II | NEOADJUVANT THERAPY | ADJUVANT THERAPY | FLUOROURACIL | PATHOLOGICAL COMPLETE RESPONSE | RADIATION-THERAPY | 5-FLUOROURACIL | ONCOLOGY | PREOPERATIVE RADIOTHERAPY | CHEMORADIATION | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Antibodies, Monoclonal, Humanized | Fluorouracil - administration & dosage | Fluorouracil - adverse effects | Aged, 80 and over | Adult | Camptothecin - administration & dosage | Deoxycytidine - adverse effects | Female | Rectal Neoplasms - pathology | Rectal Neoplasms - drug therapy | Camptothecin - analogs & derivatives | Camptothecin - adverse effects | Drug Administration Schedule | Fluorouracil - analogs & derivatives | Rectal Neoplasms - surgery | Deoxycytidine - administration & dosage | Lymphatic Metastasis | Combined Modality Therapy - adverse effects | Remission Induction | Rectal Neoplasms - radiotherapy | Proctitis - etiology | Nausea - etiology | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Vomiting - etiology | Diarrhea - etiology | Aged | Combined Modality Therapy - methods | Leukopenia - etiology | Deoxycytidine - analogs & derivatives | Clinical trials | Radiotherapy | Index Medicus | SURGERY | PATIENTS | VOMITING | DIARRHEA | NEOPLASMS | RECTUM | DEATH | RADIATION DOSES | TOXICITY | POLYMERASE CHAIN REACTION | PROCTITIS | LIVER | NAUSEA | RADIOLOGY AND NUCLEAR MEDICINE | RADIOTHERAPY | SKIN | COMBINED THERAPY | AMINOTRANSFERASES
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2011, Volume 81, Issue 4, pp. 1032 - 1038
Purpose Mutations in KRAS and BRAF genes as well as the loss of expression of phosphatase and tensin homolog (PTEN) (deleted on chromosome 10) are associated... 
Radiology | Hematology, Oncology and Palliative Medicine | PTEN | BRAF | KRAS | Cetuximab | Chemoradiotherapy | PLUS IRINOTECAN | PHASE-II | NEOADJUVANT THERAPY | MONOCLONAL-ANTIBODY | COMBINATION | METASTATIC COLORECTAL-CANCER | PATHOLOGICAL COMPLETE RESPONSE | ONCOLOGY | PREOPERATIVE CETUXIMAB | CHEMORADIATION | RADIOTHERAPY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Capecitabine | Humans | Middle Aged | Male | Neoplasm Staging - methods | Antibodies, Monoclonal, Humanized | Fluorouracil - administration & dosage | Rectal Neoplasms - genetics | Aged, 80 and over | Biomarkers, Tumor - metabolism | Adult | Camptothecin - administration & dosage | Female | Remission Induction - methods | Camptothecin - analogs & derivatives | Genes, ras - genetics | Radiotherapy Dosage | Chemoradiotherapy - methods | Drug Administration Schedule | Fluorouracil - analogs & derivatives | Deoxycytidine - administration & dosage | PTEN Phosphohydrolase - metabolism | Rectal Neoplasms - therapy | Rectal Neoplasms - mortality | Chemoradiotherapy, Adjuvant - methods | Disease-Free Survival | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Proto-Oncogene Proteins B-raf - genetics | Aged | Rectal Neoplasms - metabolism | Mutation | Deoxycytidine - analogs & derivatives | Care and treatment | Epidermal growth factor | Phosphatases | Gene mutations | Genes | Colorectal cancer | Genetic aspects | Metastasis | Cancer | ANTIBODIES | PATIENTS | NEOPLASMS | RECTUM | BIOPSY | GENE MUTATIONS | METASTASES | RADIATION DOSES | CHROMOSOMES | GROWTH FACTORS | GENES | RADIOLOGY AND NUCLEAR MEDICINE | RECEPTORS | COMBINED THERAPY
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2009, Volume 75, Issue 4, pp. 1187 - 1195
Objectives Adjuvant radiochemotherapy improves survival of patients with advanced gastric cancer. We assessed in two sequential cohorts whether improved... 
Radiology | Hematology, Oncology and Palliative Medicine | XELOX | 3D-CRT | IMRT | Gastric cancer | Survival | PROGNOSTIC-FACTORS | ADENOCARCINOMA | TARGET VOLUMES | FOLLOW-UP | PHASE-II | CHEMORADIOTHERAPY | CHEMOTHERAPY | RADIATION-THERAPY | RANDOMIZED TRIAL | ONCOLOGY | UPPER ABDOMEN | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Leucovorin - administration & dosage | Follow-Up Studies | Capecitabine | Humans | Middle Aged | Male | Organoplatinum Compounds - administration & dosage | Fluorouracil - administration & dosage | Adult | Female | Chemotherapy, Adjuvant | Radiotherapy, Adjuvant | Radiotherapy Dosage | Stomach Neoplasms - radiotherapy | Drug Administration Schedule | Fluorouracil - analogs & derivatives | Deoxycytidine - administration & dosage | Radiotherapy, Intensity-Modulated - methods | Biomarkers - blood | Stomach Neoplasms - drug therapy | Kidney - radiation effects | Radiation Injuries - prevention & control | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Radiation Injuries - blood | Creatinine - blood | Aged | Stomach Neoplasms - mortality | Deoxycytidine - analogs & derivatives | Cohort Studies | Radiotherapy, Conformal - methods | Chemotherapy | Radiotherapy | Espionage, German | Stomach cancer | Patient outcomes | Cancer | Index Medicus | NEOPLASMS | TOXICITY | MEDICINE | NUCLEAR MEDICINE | KIDNEYS | ORGANS | SURVIVAL TIME | DISEASES | THERAPY | RADIOLOGY AND NUCLEAR MEDICINE | RADIOTHERAPY | BODY | RADIOLOGY
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2009, Volume 73, Issue 1, pp. 142 - 147
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2008, Volume 72, Issue 5, pp. 1544 - 1550
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2015, Volume 373, Issue 8, pp. 726 - 736
Journal Article
Radiology and Oncology, ISSN 1318-2099, 06/2013, Volume 47, Issue 2, pp. 166 - 175
Agents targeting the epidermal growth factor receptor (EGFR) are amongst the most extensively used of the targeted agents in the therapy of some of the most... 
acne-like skin rash | erlotinib | cetuximab | gefitinib | panitumumab | antibiotics | vitamin K | Antibiotics | Erlotinib | Acne-like skin rash | Panitumumab | Cetuximab | Gefitinib | Vitamin k | Side effects | Chemotherapy | Epidermal growth factor | Clinical trials | Skin diseases | Clinical outcomes | Meta-analysis
Journal Article
Oncology Research and Treatment, ISSN 2296-5270, 11/2012, Volume 35, Issue 11, pp. 634 - 636
Journal Article
Oncology Research and Treatment, ISSN 2296-5270, 03/2009, Volume 32, Issue 3, pp. 152 - 152
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.